Preis:
82.90 EUR (kostenfreier Versand)
Preis inkl. Versand:
82.90 EUR
Alle Preisangaben inkl. USt
Verkauf durch:
Fundus-Online GbR
Daniel Borkert/Gilbert Schwarz/Urban Zerfaß
Kurfürstenstr. 14
10785 Berlin
DE
Zahlungsarten:
Rückgabemöglichkeit:
Ja (Weitere Details)
Versand:
Büchersendung / ab 60 Euro frei!
Lieferzeit:
1 - 3 Werktage
Beschreibung:
153 S. Fadengehefteter Originalpappband.
Bemerkung:
Tadellos, nahezu ohne Gebrauchsspuren. - Inhalt: Introduction / David S. Alberts and Setsuko K. Chambers -- Current Chemotherapy of Ovarian Cancer / Michael A. Bookman -- Principles of Intraperitoneal Chemotherapy / Maurie Markman -- Intraperitoneal Chemotherapy: Phase III Trials / David S. Alberts and Mary C. Clouser -- Criteria for Using Intraperitoneal (IP) Chemotherapy for Advanced Ovarian Cancer / Richard R. Barakat -- Selection and Placement of Intraperitoneal Catheters for IP Chemotherapy for Ovarian Cancer / Joan Walker -- Selection of Drugs for Intraperitoneal Chemotherapy for Ovarian Cancer / Stephen B. Howell -- Administration Guidelines for Intraperitoneal Chemotherapy for Ovarian Cancer / Deborah K. Armstrong -- Novel Drugs for Intraperitoneal Therapy for Ovarian Cancer / Boris Kobrinsky and Franco Muggia -- Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: An Ongoing Research Effort / Paul H. Sugarbaker -- Health-Related Quality of Life and Patient-Reported Outcomes / Lisa M. Hess. - Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training. (Verlagstext). ISBN 9783642121296